BD2-27596-29572
5 vaccinations
24 coded responses
62 check-ins
24 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 921 / CA
- Registered
- 2021-05-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-03
Registered in v-safe
-
2021-05-03
Dose 1 — Pfizer-BioNTech
- 2021-05-03
-
2021-05-04
Survey response — days 1–6 daily, dose 1MedDRA: Frequent bowel movements — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: FREQUENT BOWEL MOVEMENTSMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-05-08
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Good · Site: PainFree text: SHORTNESS OF BREATHMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: GoodFree text: SHORTNESS OF BREATHMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-10
- 2021-05-17
-
2021-05-24
Dose 2 — Pfizer-BioNTech
-
2021-05-24
Survey response — day 0, dose 2MedDRA: Somnolence — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches · Be unable to workFree text: DROWSINESSMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-26
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: CHEST CONGESTIONMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-29
- 2021-05-30
- 2021-05-31
- 2021-06-07
- 2021-06-14
- 2021-06-21
- 2021-06-28
- 2021-07-05
-
2021-08-23
Survey response — 3 months, dose 2MedDRA: Cough, Diarrhoea, Fatigue, Lower respiratory tract infection, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test negative, Secretion discharge, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Respiratory cold for last 3 weeks: diarrhea and fatigue followed by sneezing and nasal discharge, ending with two weeks of a chest cold with occasional coughing and lots of mucous.Took COVID test - NegativeMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-23
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-11-22
Survey response — 6 months, dose 2MedDRA: Dyspnoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: SHORTNESS OF BREATH WHILE AT HIGH ELEVATION -- LASTED ABOUT 12 HOURS.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-30
Dose 3 — Moderna
-
2021-12-03
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolFree text: RUNNY NOSE, SORE THROATMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Fever · Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: RUNNY NOSE, CONGESTIONMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Fair · Fever · Fatigue or tirednessFree text: RUNNY NOSE, NASAL CONGESTIONMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Fair · Fatigue or tirednessFree text: NASAL DRIP, CONGESTION, COUGHINGMedDRA releases: 2024-11 · check-in free text available
-
2021-12-07
Health check-in — day 7, dose 3Feeling: Good · Fever · Joint pains, Muscle or body achesAdult check-in
- 2021-12-10
- 2021-12-14
- 2021-12-21
- 2021-12-28
-
2022-01-04
Survey response — day 35, dose 3MedDRA: Cough, Increased viscosity of upper respiratory secretion — Feeling: GoodFree text: Dry cough, Thicker mucousMedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
-
2022-03-01
Survey response — 3 months, dose 3MedDRA: Respiratory tract infection — Feeling: GoodFree text: RESPIRATORY INFECTION, NO FEVERMedDRA releases: 2024-11 · check-in free text available
-
2022-04-12
Dose 4 — Moderna
-
2022-04-12
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2022-04-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-14
-
2022-04-15
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: Good · Site: PainFree text: DAY 2 of SORE THROATMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: Good · Site: PainFree text: DAY 3, SORE THROATMedDRA releases: 2024-11 · check-in free text available
- 2022-04-17
-
2022-04-18
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: Fair · Fever · Fatigue or tiredness, NauseaFree text: SORE THROATMedDRA releases: 2024-11 · check-in free text available
- 2022-04-19
- 2022-04-26
- 2022-05-03
- 2022-05-10
- 2022-05-17
-
2022-05-24
Survey response — day 42, dose 4MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: SORE THROAT and NASAL CONGESTIONMedDRA releases: 2024-11 · check-in free text available
-
2022-07-12
Survey response — 3 months, dose 4MedDRA: Headache, Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: HEADACHE NASAL CONGESTION SORE THROATMedDRA releases: 2024-11 · check-in free text available
-
2022-09-15
Dose 5 — Pfizer-BioNTech
-
2022-09-15
Survey response — day 0, dose 5MedDRA: Dizziness — Feeling: Fair · Site: Swelling · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Survey response — days 1–6 daily, dose 5MedDRA: Sinus congestion — Feeling: Fair · Site: Pain · Fever · Headache, DiarrheaFree text: SINUS CONGEDTIONMedDRA releases: 2024-11 · check-in free text available
-
2022-09-17
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2022-09-18
- 2022-09-19
-
2022-09-21
Survey response — days 1–6 daily, dose 5MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Good · DiarrheaFree text: SORE THROAT and NASAL CONGESTIONMedDRA releases: 2024-11 · check-in free text available
- 2022-09-22
-
2022-09-29
Survey response — day 14, dose 5MedDRA: Fatigue — Feeling: FairFree text: FATIGUEMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Survey response — day 21, dose 5MedDRA: Chills, Diarrhoea, Pain, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: RUNNY NOSE, FEVER, CHILLS, BODY ACHES, DIARRHEAMedDRA releases: 2024-11 · check-in free text available
- 2022-10-13
- 2022-10-22
-
2022-10-27
Survey response — day 42, dose 5MedDRA: Abdominal pain, Diarrhoea — Feeling: GoodFree text: LOOSE STOOLS, ABDOMINAL CRAMPSMedDRA releases: 2024-11 · check-in free text available
- 2022-12-15
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-03 | Pfizer-BioNTech | |
| 2 | 2021-05-24 | Pfizer-BioNTech | |
| 3 | 2021-11-30 | Moderna | No |
| 4 | 2022-04-12 | Moderna | No |
| 5 | 2022-09-15 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): FREQUENT BOWEL MOVEMENTS
Systemic reaction (other): SHORTNESS OF BREATH
Systemic reaction (other): SHORTNESS OF BREATH
Release 8 — day 0, dose 2
Systemic reaction (other): DROWSINESS
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): CHEST CONGESTION
Release 9 — 3 months, dose 2
Symptoms: Respiratory cold for last 3 weeks: diarrhea and fatigue followed by sneezing and nasal discharge, ending with two weeks of a chest cold with occasional coughing and lots of mucous.Took COVID test - Negative
Release 10 — 6 months, dose 2
Symptoms: SHORTNESS OF BREATH WHILE AT HIGH ELEVATION -- LASTED ABOUT 12 HOURS.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): RUNNY NOSE, SORE THROAT
Systemic reaction (other): RUNNY NOSE, CONGESTION
Systemic reaction (other): RUNNY NOSE, NASAL CONGESTION
Systemic reaction (other): NASAL DRIP, CONGESTION, COUGHING
Release 10 — day 35, dose 3
Symptoms: Dry cough, Thicker mucous
Release 11 — 3 months, dose 3
Symptoms: RESPIRATORY INFECTION, NO FEVER
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): DAY 2 of SORE THROAT
Systemic reaction (other): DAY 3, SORE THROAT
Systemic reaction (other): SORE THROAT
Release 11 — day 42, dose 4
Symptoms: SORE THROAT and NASAL CONGESTION
Release 12 — 3 months, dose 4
Symptoms: HEADACHE NASAL CONGESTION SORE THROAT
Release 12 — day 0, dose 5
Systemic reaction (other): Dizziness
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): SINUS CONGEDTION
Systemic reaction (other): SORE THROAT and NASAL CONGESTION
Release 12 — day 14, dose 5
Symptoms: FATIGUE
Release 12 — day 21, dose 5
Symptoms: RUNNY NOSE, FEVER, CHILLS, BODY ACHES, DIARRHEA
Release 12 — day 42, dose 5
Symptoms: LOOSE STOOLS, ABDOMINAL CRAMPS
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Diarrhoea | ✓ | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Increased viscosity of upper respiratory secretion | · | · | ✓ |
| SD | Lower respiratory tract infection | ✓ | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Secretion discharge | ✓ | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Frequent bowel movements | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sinus congestion | · | · | ✓ |
| SRO | Somnolence | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release